10th RWE, Market Access, Pricing & Reimbursement 2023 Americas
30th November - 1st December 2023
COMING SOON! 50 + KEY INDUSTRY EXPERT SPEAKERS

Jason M. Noto
Senior Vice President, US Market Access
Jason Noto serves as Senior Vice President of US Market Access at AVEO Oncology, an LG Chem Company. Since 2019, Jason has led all aspects of Market Access (Trade & Distribution, National Accounts, HUB Services, Federal Channels, and Pricing / Contracting) and spearheaded the commercial buildout of the Function for the launch of FOTIVDA (tivozanib) for advanced Renal Cell Carcinoma in March, 2020. Prior to his time at AVEO, Jason spent 12 years in US Marketing roles with increasing responsibility at Bristol-Myers Squibb, Alkermes, and Sunovion Pharmaceuticals and has led the commercial launch of 7 specialty products over the span of his marketing tenure. Jason started his career in 2000 in sales and sales management roles spanning oncology, rare disease, and CNS therapeutic areas.
Jason graduated from LeMoyne College with a Bachelor’s Degree in Marketing and earned his Masters of Business Administration (MBA) from the Carroll School of Management at Boston College.

Danielle Bargo
Director, RWE & US HEOR Lead
Danielle Bargo is a Health Economist in the pharmaceutical industry with over 10 years of experience generating and using evidence to inform drug pricing and reimbursement decisions. Danielle is currently a Director in the Real World Evidence and Health Economics and Outcomes Research team at Eisai, and an advisor on the Patient-Centered Outcomes Research Institute (PCORI) Clinical Effectiveness and Decision Science. Prior to Eisai, she was the Head of Health Technology Assessments at Flatiron Health and a Global HEOR Lead at Pfizer.
Danielle earned a BA in Political Science from Butler University, a MSc in Social Policy from the London School of Economics and Political Science and is currently a Doctor of Public Health student in Health Policy at the Johns Hopkins Bloomberg School of Public Health.

EUGEAN JIWANMALL
Senior Research Analyst for Medical Policy & Technology Evaluation, Independence Blue Cross
Independence Blue Cross

EUGEAN JIWANMALL
Senior Research Analyst for Medical Policy & Technology Evaluation, Independence Blue Cross
Eugean Jiwanmall’s past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross’ Medical & Claim Payment Policy Department within Facilitated Health Networks and Medical Affairs, he has served as the subject-matter-expert, writer, reviewer, communicator, presenter, consultant, adviser/facilitator, and decision-maker for hundreds of medical policy topics and technology assessments within dozens of clinical disciplines and multiple business areas. Eugean has participated in numerous roles & capacities in a number of conferences, summits, and other national & international events etc. upon invitations. He has been invited by renowned organizations, evaluator bodies, & thinktanks etc. to be key informant on a variety of complex and challenging topics, and recognized in communications & publications for these works. Eugean has taken and completed graduate coursework in bioethics at the University of Pennsylvania School of Medicine. He holds a bachelor’s degree in biological sciences with honors from Drexel University (minor was in business administration), a master’s degree of public health in evaluative clinical sciences from Dartmouth Medical School, and an MBA in healthcare management and economics with honors from Drexel University.